A review of ropinirole prolonged release in Parkinson’s disease

Ropinirole prolonged release is a once-daily, 24-hour formulation of ropinirole, a non-ergot dopamine agonist. It is approved as monotherapy and as an adjunct to levodopa in the treatment of Parkinson’s disease (PD). Several potential advantages of ropinirole prolonged release compared to the immedi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Nashatizadeh, Muhammad M, Lyons, Kelly E, Pahwa, Rajesh
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2009
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2685238/
https://ncbi.nlm.nih.gov/pubmed/19503779
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller